Alpine Immune Sciences Inc (NASDAQ:ALPN)

10.15
BATS BZX Real-Time Price
As of 10:04am ET
 -0.29 / -2.78%
Today’s Change
2.05
Today|||52-Week Range
15.00
+164.32%
Year-to-Date
Alpine Immune Sciences secures equity capital of $60M
Jul 24 / Seeking Alpha - Paid Partner Content
 

Today’s Trading

Previous close10.44
Today’s open10.22
Day’s range10.10 - 10.22
Volume658
Average volume (3 months)591,621
Market cap$191.7M
Data as of 10:04am ET, 08/11/2020

Growth & Valuation

Earnings growth (last year)+13.47%
Earnings growth (this year)+72.51%
Earnings growth (next 5 years)--
Revenue growth (last year)+146.81%
P/E ratioNM
Price/Sales40.52
Price/Book6.50

Competitors

 Today’s
change
Today’s
% change
NCNANuCana PLC-0.15-2.53%
TLCTaiwan Liposome Co L...-0.09-1.70%
AXLAAxcella Health Inc+0.01+0.19%
MREOMereo BioPharma Grou...0.000.00%
Data as of 10:04am ET, 08/11/2020

Financials

Next reporting dateAugust 12, 2020
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$1.7M
Annual profit (last year)-$41.9M
Net profit margin-2,405.29%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Seattle, Washington

Forecasts